For Healthcare Professionals

Click here if you would like to find out more information about OPDIVO® (nivolumab)

Report adverse events

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

Adverse events should also be reported to Bristol-Myers Squibb Medical Information on 0800 731 1736

For patients

Click here if you would like to find out more about your treatment with OPDIVO® (nivolumab)

Report possible side effects

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.This includes any possible side effects not listed in the package leaflet. See www.mhra.gov.uk/yellowcard for how to report side effects. Side effects should also be reported to Bristol-Myers Squibb Medical Information on 0800 731 1736 or medical.information@bms.com.

For members of the general public

Click here if you would like to find out some general information on OPDIVO® (nivolumab)

This medicine is subject to additional monitoring. This will allow quick identification of new safety information.

Privacy Policy Legal notice

1506UK1600145-01
Date of preparation: May 2016